01.08.2007 10:00:00
|
Acacia Technologies Acquires Rights to Patent for Multi-Dimensional Database Compression Technology
Acacia Research Corporation (Nasdaq:ACTG)(Nasdaq:CBMX) announced today
that Acacia Patent Acquisition Corporation, a wholly owned subsidiary
that is part of the Acacia Technologies group, a leader in technology
licensing, has acquired rights to a patent relating to multi-dimensional
database compression technology.
"Acacia continues to grow its base of future
revenues by adding new patent portfolios,”
commented Paul Ryan, Acacia Chairman and CEO. "As
our licensing success grows, more companies are selecting us as their
partner for the licensing of their patented technologies,”
concluded Mr. Ryan.
This patented technology generally relates to the compression of
databases. The technology enables the compressed information to be
accessible in real time and generates cost savings in enterprise storage.
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research Corporation comprises two operating groups, Acacia
Technologies group and CombiMatrix group.
The Acacia Technologies group develops, acquires, and licenses patented
technologies. Acacia controls 77 patent portfolios, which include U.S.
patents and certain foreign counterparts, covering technologies used in
a wide variety of industries including audio/video enhancement &
synchronization, broadcast data retrieval, computer memory cache
coherency, credit card fraud protection, database management, data
encryption & product activation, digital media transmission (DMT®),
digital video production, dynamic manufacturing modeling, enhanced
Internet navigation, image resolution enhancement, interactive data
sharing, interactive television, laptop docking station connectivity,
microprocessor enhancement, multi-dimensional bar codes, resource
scheduling, spreadsheet automation, and user activated Internet
advertising.
The CombiMatrix group is developing a platform technology to rapidly
produce customizable arrays, which are semiconductor-based tools for use
in identifying and determining the roles of genes, gene mutations and
proteins. The CombiMatrix's group's technology has a wide range of
potential applications in the areas of genomics, proteomics, biosensors,
drug discovery, drug development, diagnostics, combinatorial chemistry,
material sciences and nanotechnology.
Acacia Research-Acacia Technologies (Nasdaq:ACTG) and Acacia
Research-CombiMatrix (Nasdaq:CBMX) are both classes of common stock
issued by Acacia Research Corporation and are intended to reflect the
performance of the respective operating groups and are not issued by the
operating groups.
Information about the Acacia Technologies group and the CombiMatrix
group is available at www.acaciaresearch.com.
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995 This news release contains forward-looking statements within the
meaning of the "safe harbor”
provisions of the Private Securities Litigation Reform Act of 1995. These
statements are based upon our current expectations and speak only as of
the date hereof. Our actual results may differ materially and
adversely from those expressed in any forward-looking statements as a
result of various factors and uncertainties, including the recent
economic slowdown affecting technology companies, our ability to
successfully develop products, rapid technological change in our
markets, changes in demand for our future products, legislative,
regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K, recent and forthcoming Quarterly
Reports on Form 10-Q, recent Current Reports on Forms 8-K and 8-K/A, and
other SEC filings discuss some of the important risk factors that may
affect our business, results of operations and financial condition. We
undertake no obligation to revise or update publicly any forward-looking
statements for any reason.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!